UNSPSC 51182006: Trenbolone

This classification denotes an anabolic steroid with the molecular formula C18H22O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, P53R4420TR chemically known as estra-4,9,11-trien-3-one, 17-hydroxy-, (17.beta.)- but generally known as trenbolone, which bears US NIH Compound Identifier 25015. European Medicines Agency schedules Trenbolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11232MIG.

UNSPSC 51182006 Trenbolone, a Commodity code, sees limited direct state and local procurement activity; the single recent opportunity under this code is a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon. The scope under this code nominally covers anabolic steroids, but the MMCAP solicitation itself is generic pharmaceutical procurement that may not involve trenbolone specifically — the RFP seeks manufacturers to supply comprehensive pricing for identified pharmaceutical products with specific National Drug Codes, and trenbolone's presence in state and local procurement remains unclear from the available documentation. Issuing bodies using this code include multistate cooperative purchasing alliances administering pharmaceutical contracts on behalf of participating state agencies and local government facilities; MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, is the identified repeat buyer for pharmaceutical commodity procurement across member jurisdictions.

The MMCAP RFP, posted January 20, 2026 with responses due March 26, 2026, requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and demonstrates the administrative infrastructure state and local buyers expect: certification of current Good Manufacturing Practices compliance and Drug Supply Chain Security Act compliance, maintenance of contractual relationships with at least two authorized wholesalers, comprehensive insurance including $5 million commercial general liability per occurrence, EDI capability, and pricing flexibility through flat price, net price, or WAC-minus structures. The contract term runs two years for new responders with optional extensions at MMCAP's sole discretion, effective July 1, 2026, and vendors incur a 3 percent administrative fee on all purchases with performance penalties ranging from $200 to $1,500 per violation. Geographic activity under this code is concentrated in the Upper Midwest, specifically Minnesota and Oregon, through the MMCAP vehicle.